Serial evaluation of increased chest wall F-18 fluorodeoxyglucose (FDG) uptake following radiation therapy in patients with bronchogenic carcinoma

Clinical Positron Imaging (Netherlands)

Volumn 1, Issue 3, 1998, Pages 185-191

  Lowe, Val J ^a   Hebert, Mary E ^b   Anscher, Mitchell S ^c   Coleman, R Edward ^c  

^a SAINT LOUIS UNIVERSITY   (United States)

^b Treasure Coast Rad One Center   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

F 18 fluorodeoxyglucose (FDG); Lung neoplasms; Positron emission tomography (PET); Therapeutic radiology; Treatment planning

Indexed keywords

EID: 6044220154     PISSN: 10950397     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1095-0397(98)00013-2     Document Type: Article

References (15)

1. G.L. Becker W.L. Whitlock P.S. Schaefer M.F. Tenholder The impact of thoracic computed tomography in clinically staged T1, N0, M0 chest lesions Arch. Intern. Med. 150 1990 557 559
2. D. Recine K. Rowland S. Reddy Combined modality therapy for locally advanced non-small cell lung carcinoma Cancer 66 1990 2270 2278
3. R.J. Ginsberg M.G. Kris J.G. Armstrong Cancer of the Lung V.T. DeVita S. Hellman S.A. Rosenberg Cancer. Principles and practice of oncology 4 1993 J.B. Lippencott Co Philadelphia
4. J.D. Cox N. Azarnia R.W. Byhardt K.Y. Shin B. Emami T.F. Pajak A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy. Possible survival benefit with > 69.9 Gy in favorable patients with Stage III non-small cell lung cancer Report of Radiation Therapy Oncology Group 83-11 J. Clin. Oncol. 8 1990 1543 1555
5. D.G. Bragg Current applications of imaging procedures in the patient with lung cancer Int. J. Radiat. Oncol. Biol. Phys. 21 1991 847 851
6. O. Warburg The metabolism of tumors 1930 Constable London
7. G. Weber Enzymology of cancer cells. Part I N. Engl. J. Med. 296 1977 468 492
8. G. Weber Enzymology of cancer cells. Part II N. Engl. J. Med. 296 1977 541 551
9. N.C. Gupta A.R. Frank N.A. Dewan Solitary pulmonary nodules detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose Radiology 184 1992 441 444
10. E.F. Patz V.J. Lowe J.M. Hoffman Focal pulmonary abnormalities evaluation with F-18 fluorodeoxyglucose PET scanning Radiology 188 1993 487 490
11. Y. Ichiya T. Kuwabara M. Otsuka Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography J. Nucl. Med. 32 1991 1655 1660
12. E.F. Patz V.J. Lowe J.M. Hoffman S. Paine L. Harris P.C. Goodman Detection of persistent or recurrent bronchogenic carcinoma causing 18F-2-Deoxy-D-glucose and positron emission tomography (PET) imaging Radiology 191 1994 378 384
13. R. Kubota K. Kubota S. Yamada M. Tada T. Ido N. Tamahashi Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake J. Nucl. Med. 35 1994 104 112
14. R.E. Carson M.E. Daube-Witherspoon M.V. Green A method for postinjection PET transmission measurements with a rotating source J. Nucl. Med. 29 1988 1558 1567
15. N.C. Gupta N.A. Dewan A. Frank Diagnostic evaluation of suspected solitary pulmonary nodules (SPN) using PET FDG imaging Chest 104 1993 119S